On Demand 2019 Friday General Sessions

This collection covers general sessions from Friday's program. This includes plenaries, and symposia. The sessions listed below are included in this package:

  • AACA 2019: Subcutaneous vs Sublingual Allergen Immunotherapy—Where Do We stand in 2019?
  • Idiopathic Anaphylaxis - Knowledge Gaps and Patient Needs
  • Phases of Allergy Practice
  • Biologics for The Young and The Restless
  • Across the Spectrum of Immunotherapy
  • Luncheon Symposium - Implementing Food Allergy Therapy in Clinical Practice
  • Don't be Rash! Assessing Contact Dermatitis
  • Pearls to Improve Your Practice Operations
  • Physician Health and Wellness: Advocating for Ourselves
  • Evidence-Based Diagnosis of Food Allergy

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 12.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Of the AMA PRA Category 1 Credits™ listed above, the ABAI has designated a maximum of 1.5 credits as meeting the requirements for MOC Part II Self-Assessment.

Target Audience

Medical professionals who treat patients with allergic and/or immunological conditions:

  • Practicing allergist/immunologists
  • Allergy/immunology Fellows-in-Training
  • Physician assistants
  • Nurses and advanced practice nurses
  • Allied health professionals
  • Primary care physicians
  • Other medical professionals

Learning Objectives

Upon completion of this session, participants should be able to:

  • Compare the usage of SCIT versus SLIT in the U.S. and internationally Examine the long and short term efficacy of SLIT for grass pollen seasonal allergy.
  • Identify the efficacy of SLIT for grass and ragweed pollen in children.
  • Identify the efficacy of SLIT for ragweed pollen seasonal allergy.
  • Recognize the efficacy of SLIT for dust mite allergy. Recognize the efficacy of SLIT for dust mite in children.
  • Differentiate the efficacy of SLIT in patient with allergic rhinitis and concomitant asthma.
  • Recognize the comparative efficacy of SLIT versus SCIT in pollen allergy and dust mite allergy.
  • Differentiate the safety of SLIT versus SCIT including recent U.S. data.
  • Identify the appropriate patient to select for SCIT versus SLIT.
  • Summarize the mechanisms underlying SLIT versus SCIT.
  • Describe the incidence and prevalence of anaphylaxis NYD.
  • Initiate an appropriate work up for mast cell disorders in the idiopathic anaphylaxis setting.
  • Describe the differential diagnosis of recurrent idiopathic anaphylaxis.
  • Differentiate the biologic agents used for severe asthma.
  • Describe the indications for biologic therapy for CRS.
  • Understand emerging development of biologic therapy for food allergy.
  • Understand mechanism(s) for rush and cluster IT.
  • Identify appropriate patients for rush and cluster IT.
  • Identify potential risks with these therapies.
  • Summarize clinical trial data on the efficacy and safety of novel immunologic treatments for peanut allergy.
  • Adopt practical strategies for implementing food allergy immunotherapy in a clinical practice setting. Select appropriate candidates for food allergy immunotherapy.
  • Provide patients and families/caregivers with appropriate guidance on the use of novel immunologic treatments for food allergy.
  • Describe the immunology and the pathophysiology of contact dermatitis and irritant dermatitis and the differences between them.
  • Recognize the various patterns of contact dermatitis and gain knowledge on how to correlate location of the rash with causative agents.
  • Diagnose, treat and educate patients on pertinent allergen avoidance and location of reference materials.
  • Formulate and categorize the multiple causes of provider burnout and stress.
  • Demonstrate the ability to summarize the current scientific literature involving provider health and wellness, including allergy/immunology data.
  • Compare and contrast potential solutions to provider stress and burnout, specifically with regards to allergy and immunology providers.
  • Detail the indications for when to test for peanut allergy and what test to run.
  • Understand the potential role for peanut allergy component testing.
  • Describe the evidence surrounding whether diagnostic testing for peanut allergy can be used to infer future reaction severity.
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma & Immunology (ACAAI) policy, the College must identify and resolve conflicts of interest for all individuals responsible for the development, management, presentation, and/ or evaluation relevant to a CME activity. Disclosed information is reviewed in advance in order to manage and resolve any potential conflicts of interest. Disclosure in no way implies that the information presented is biased or of lesser quality; it is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.

Specific disclosure information for the 2019 Annual Meeting is available online and via the meeting app

Course summary
Available credit: 
  • 12.50 AMA PRA Category 1 Credit™
  • 12.50 Attendance
  • 1.50 MOC
Course opens: 
12/01/2019
Course expires: 
11/30/2022
Rating: 
0

Aikaterini Anagnostou, MD, PhD, FACAAI

William C. Anderson, MD

William E. Berger, MD, MBA, FACAAI

Moises Calderon-Zapata, MD, PhD

Warner W. Carr, MD, FACAAI

Thomas B. Casale, MD, FACAAI

Nicole M. Chase, MD

Jonathan Corren, MD, FACAAI

Carla M. Davis, MD, FACAAI

Lawrence M. DuBuske, MD, FACAAI

Anne K. Ellis, MD, MSc, FACAAI

Ira Finegold, MD, FACAAI

Stanley M. Fineman, MD, MBA, FACAAI

Joseph P. Forester, DO, FACAAI

Sandra M. Gawchik, DO, FACAAI

David B.K. Golden, MD, FACAAI

Paul A. Greenberger, MD, FACAAI

Matthew Greenhawt, MD, MSc, MBA, FACAAI

 Gary N. Gross, MD, FACAAI

Whitney A. High, MD, MEng

Jonathan Hourihane, MD

Sharon E. Jacob, MD

Douglas H. Jones, MD, FACAAI

Edwin H. Kim, MD, FACAAI

Jay A. Lieberman, MD, FACAAI

Phillip L. Lieberman, MD, FACAAI

Douglas Mack, MD, MSc

Gailen D. Marshall, MD, PhD, FACAAI

Stephanie Mawhirt, DO

Kathleen R. May, MD, FACAAI

Scott McCutcheon, MHA

Kevin P. McGrath, MD, FACAAI

Travis A. Miller, MD, FACAAI

Anil Nanda, MD, FACAAI

Maeve E. O'Connor, MD, FACAAI

John J. Oppenheimer, MD, FACAAI

Jean Owen, MBA

Jay M. Portnoy, MD, FACAAI

Melinda M. Rathkopf, MD, FACAAI

Russell Settipane, MD, FACAAI

Marcus Shaker, MD, MSc, FACAAI

Sandy Skotnicki, MD

J. Wesley Sublett, MD, MPH, FACAAI

James L. Sublett, MD, FACAAI

Mike Tankersley, MD, MBA, FACAAI

James M. Tracy, DO, FACAAI

Dana V. Wallace, MD, FACAAI

Julie Wang, MD, FACAAI

Available Credit

  • 12.50 AMA PRA Category 1 Credit™
  • 12.50 Attendance
  • 1.50 MOC

Accreditation Period

Course opens: 
12/01/2019
Course expires: 
11/30/2022
Please login or create an account to take this course.